Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.600
-0.012 (-1.96%)
At close: Apr 28, 2026, 4:00 PM EDT
0.600
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Cytosorbents Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 37.06 | 35.6 | 31.08 | 34.69 | 43.17 | Upgrade
|
| Revenue | 37.06 | 35.6 | 31.08 | 34.69 | 43.17 | Upgrade
|
| Revenue Growth (YoY) | 4.12% | 14.51% | -10.39% | -19.64% | 5.27% | Upgrade
|
| Cost of Revenue | 10.57 | 10.71 | 9.13 | 13.96 | 11.05 | Upgrade
|
| Gross Profit | 26.49 | 24.89 | 21.95 | 20.73 | 32.12 | Upgrade
|
| Selling, General & Admin | 35.65 | 33.73 | 38.31 | 36.5 | 38.48 | Upgrade
|
| Research & Development | 5.09 | 7.61 | 15.59 | 15.12 | 16.38 | Upgrade
|
| Operating Expenses | 40.73 | 41.34 | 53.9 | 51.62 | 54.86 | Upgrade
|
| Operating Income | -14.24 | -16.45 | -31.95 | -30.89 | -22.74 | Upgrade
|
| Interest Expense | -2.61 | -1.4 | -0.16 | - | - | Upgrade
|
| Interest & Investment Income | - | - | - | 0.13 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 9.32 | -4.23 | 1.95 | -2.45 | -2.58 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0.1 | -0.07 | - | Upgrade
|
| EBT Excluding Unusual Items | -7.53 | -22.08 | -30.06 | -33.27 | -25.29 | Upgrade
|
| Merger & Restructuring Charges | -0.51 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.56 | -0.33 | - | -0.64 | - | Upgrade
|
| Pretax Income | -8.6 | -22.41 | -30.06 | -33.91 | -25.29 | Upgrade
|
| Income Tax Expense | -0.4 | -1.69 | -0.81 | -1.09 | -0.74 | Upgrade
|
| Net Income | -8.2 | -20.72 | -29.25 | -32.81 | -24.56 | Upgrade
|
| Net Income to Common | -8.2 | -20.72 | -29.25 | -32.81 | -24.56 | Upgrade
|
| Shares Outstanding (Basic) | 62 | 54 | 45 | 44 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 62 | 54 | 45 | 44 | 43 | Upgrade
|
| Shares Change (YoY) | 14.32% | 21.90% | 2.49% | 0.49% | 11.70% | Upgrade
|
| EPS (Basic) | -0.13 | -0.38 | -0.65 | -0.75 | -0.57 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.38 | -0.65 | -0.75 | -0.57 | Upgrade
|
| Free Cash Flow | -12.54 | -14.71 | -22.19 | -34.32 | -17.65 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.27 | -0.50 | -0.79 | -0.41 | Upgrade
|
| Gross Margin | 71.47% | 69.92% | 70.62% | 59.77% | 74.41% | Upgrade
|
| Operating Margin | -38.42% | -46.22% | -102.78% | -89.04% | -52.69% | Upgrade
|
| Profit Margin | -22.12% | -58.21% | -94.09% | -94.59% | -56.89% | Upgrade
|
| Free Cash Flow Margin | -33.84% | -41.33% | -71.39% | -98.94% | -40.88% | Upgrade
|
| EBITDA | -12.74 | -14.88 | -30.49 | -30 | -22.01 | Upgrade
|
| EBITDA Margin | -34.38% | -41.81% | -98.08% | -86.49% | -51.00% | Upgrade
|
| D&A For EBITDA | 1.5 | 1.57 | 1.46 | 0.88 | 0.73 | Upgrade
|
| EBIT | -14.24 | -16.45 | -31.95 | -30.89 | -22.74 | Upgrade
|
| EBIT Margin | -38.42% | -46.22% | -102.78% | -89.04% | -52.69% | Upgrade
|
| Revenue as Reported | - | - | - | 34.69 | 43.17 | Upgrade
|
| Advertising Expenses | 0.3 | 0.3 | - | 0.58 | 0.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.